Skip to main content
Contact Us
Subscribe
E-Edition
54°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Aligos Therapeutics
< Previous
1
2
Next >
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
March 12, 2024
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics to Announce 4th Quarter 2023 Financial Results on March 12, 2024
March 05, 2024
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics To Participate in the Leerink Partners Global Biopharma Conference 2024
February 26, 2024
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics to Host KOL Event to Discuss Phase 2a HERALD Study of ALG-055009 in MASH on March 7, 2024
February 20, 2024
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics Strengthens Finance Leadership Team with Two New Appointments
February 13, 2024
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics Presents Positive Clinical Data at Hep-DART 2023 from Phase 1 Studies in HBV (ALG-000184) and NASH (ALG-055009)
December 07, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics To Present at the Piper Sandler Healthcare Conference
November 20, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics Presents Clinical and Nonclinical Data at the AASLD Liver Meeting® 2023 Demonstrating that ALG-055009 has a Favorable Risk-Benefit Profile
November 13, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics Presents Positive Data at the AASLD Liver Meeting® 2023 Demonstrating that Treatment with ALG-000184 (CAM-E) Results in Significant Multi-log Reductions in Hepatitis B Antigens (HBsAg, HBcrAg and HBeAg)
November 10, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics to Present Multiple Posters at AASLD’s The Liver Meeting® 2023, Highlighting Progress for Its Clinical Stage Portfolio, including Lead THR-β Agonist for the Treatment of NASH, ALG-055009; ALG-000184, the Company’s Lead CAM-E Molecule,
November 07, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics to Host KOL Event to Discuss ALG-000184 Phase 1, AASLD Late Breaker Data
November 03, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results
November 02, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics to Announce 3rd Quarter Results on November 2, 2023
October 26, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics To Present Late Breaking Poster on ALG-000184, its CAM-E Drug Candidate, at The Liver Meeting® 2023
October 25, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics Announces $92 Million Private Placement Financing
October 23, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics Announces Award of an $8.5 Million NIAID Contract to Advance Development of Best-In-Class Pan-Coronavirus Protease Inhibitor, ALG-097558
October 03, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics Announces IND Clearance for NASH lead, ALG-055009
September 21, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2023 Financial Results
August 03, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics to Announce Second Quarter Results on August 03, 2023
July 27, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics Announces the Selection of Stephen Harrison, MD as Principal Investigator of Ph2a Study and Key Study Design Elements/Milestones for NASH Drug Candidate, ALG-055009
July 19, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics Presents Data from its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023
June 21, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics to Present Data on its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023
June 07, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics to Present at the Jefferies 2023 Healthcare Conference
May 24, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics Announces Research Collaboration and Development Agreement with Xiamen Amoytop Biotech Co. Ltd. for Use of Aligos’ Oligonucleotide Platform for the Treatment of Liver Diseases
May 12, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2023 Financial Results
May 04, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics to Announce First Quarter Results on May 4, 2023
April 27, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics to Present Data from Chronic Hepatitis B and Hepatocellular Carcinoma Programs at the European Association for the Study of the Liver (EASL) Congress 2023
April 11, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics Presents Clinical Data from NASH Program at the 2023 Paris Hepatology Conference
March 29, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2022 Financial Results
March 09, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
Aligos Therapeutics to Announce Fourth Quarter Results March 9, 2023
February 28, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Tickers
ALGS
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.